PINK1 and PRKN phosphorylation, with respect to PD-linked mutations, have been assessed in vitro, and efforts of developing quantitative and highly specific assays to measure these PTMs in PINK1 and PRKN are ongoing and would provide useful insights into the effect of mutations on activation status and signaling in vivo. The gene discussed is PINK1; the disease is Parkinson disease.